WASHINGTON, 23 August 2021 / PRNewswire / – The American Association of Kidney Patients (AAKP), the largest independent kidney patient organization in the country, issued a formal statement in support of today’s Food and Drug Administration (FDA) announcement that the agency had granted Based on additional safety and efficacy data, full approval of Pfizer / BioNTech vaccine against COVID-19. The Pfizer / BioNTech vaccine and two other COVID-19 vaccines were available under the FDA’s Emergency Authorization (EUA) over the past year.
“The American Association of Kidney Patients (AAKP) thanks the US Food and Drug Administration (FDA) for full approval of the Pfizer / BioNTech vaccine, and we hope the FDA will complete its safety and efficacy review for other COVID-19- Vaccines with a Feel of As our nation battles the pandemic and the highly communicable Delta variant, unvaccinated Americans remain at high risk of developing the disease and suffering from serious complications such as acute kidney injury (AKI), long hospital stays, and death Most importantly, unvaccinated Americans pose an extremely serious risk to their families, friends, and communities, especially people whose unique susceptibility to COVID-19 infection is not apparent. These people include immunocompromised kidney transplant recipients and immunocompromised patients struggling with serious chronic diseases and other medical conditions.
We hope that with the FDA’s announcement, every American will gain confidence, consult their doctors, act responsibly, and ensure their vaccinations if they have not already done so. As kidney patients, we understand what it means to involuntarily lose health to illness, to be on a waiting list for years for organ transplants, to have shortened life expectancy from the brutality of dialysis and to see those we love suffer. Please use the miraculous gift vaccines made available to you and your family to avoid serious illness, the destruction of your dreams and longings, and the senseless and completely preventable loss of another human life.
As Americans, we must unite and show compassion for one another to defeat this pandemic, and together we must stand above the cynics who seek to undermine our shared belief in the rights and dignity of everyone in our society. “
on August 15, 2021The FDA announced the approval of a third dose of COVID-19 vaccines for highly susceptible immunocompromised patients; AAKP has also issued a Patient Impact Statement in support of this FDA decision (read here). Since the beginning of 2020 and the start of the COVID-19 crisis, AAKP has carried out an extensive national and global awareness campaign about the dangers of COVID-19 to all people and the need for greater medical innovation and more inclusive clinical trials to develop vaccines that fight the fight against the virus and new variants. AAKP content on COVID-19 can be found here https://bit.ly/AAKPCoronavirusResources.
About the American Association of Kidney Patients (AAKP): Founded in 1969, the AAKP is the largest kidney patient organization driving policy discussions about patient care choices and treatment innovations for kidney patients. By 1973, the AAKP patient collaborations with the US Congress and the White House helped ensure dialysis insurance for all those with kidney failure, creating the only disease-specific, taxpayer-funded entitlement program in America. This CMS-managed program, the End Stage Renal Disease Program (ESRD), has saved over a million lives. Over the past decade, AAKP patients have helped achieve lifelong transplant drug coverage for kidney transplant recipients (2020); new patient-centered guidelines on the White House Executive Order to Promote American Kidney Health (2019); new occupational protection for organ living under the Family Medical Leave Act (FMLA) of the US Department of Labor (2018); and Congressional Legislation Allowing HIV-Positive Organ Transplants for HIV-Positive Patients (2013). The AAKP’s virtual platforms and social networks are internationally known for their effectiveness. Follow AAKP on social media at @kidneypatient on Facebook and @kidneypatients on Twitter and visit our website at https://aakp.org/.
MEDIA CONTACT:
Jennifer rate
Marketing and Communication Manager
[email protected]
(813) 400-2394
SOURCE American Association of Kidney Patients
similar links
http://www.aakp.org
Comments are closed.